Research ArticleOriginal Article
Open Access

HbA1c and risk factors’ prevalence in patients with stroke: a retrospective study in a tertiary care hospital in Saudi Arabia

Faisal K. Alfakeeh, Yazeed M. Alghamdi, Bassam F. Alharbi, Abdulaziz M. Alotaibi, Khalid A. Alsaleh, Abdullah M. Alshubaili, Ryan H. Mcrabi, Farhan K. Alenazi and Awad Almuklass
Neurosciences Journal January 2024, 29 (1) 18-24; DOI: https://doi.org/10.17712/nsj.2024.1.20230037

References

  1. 1.↵
    1. Longo D,
    2. Harrison T.
    Harrison’s Manual of Medicine. 20th ed. New York (NY): McGraw-Hill Medical; 2020.
  2. 2.↵
    1. Katan M,
    2. Luft A.
    Global Burden of Stroke. Semin Neurol 2018; 38: 208–211.
    OpenUrlCrossRefPubMed
  3. 3.↵
    1. Tsao CW,
    2. Aday AW,
    3. Almarzooq ZI,
    4. Alonso A,
    5. Beaton AZ,
    6. Bittencourt MS, et al.
    Heart Disease and Stroke Statistics—2022 Update: A Report From the American Heart Association. Circulation 2022; 145: e153–e639.
    OpenUrlCrossRefPubMed
  4. 4.↵
    1. Ingall T.
    Stroke--incidence, mortality, morbidity and risk. J Insur Med 2004; 36: 143–152.
    OpenUrlPubMed
  5. 5.↵
    1. Alqahtani BA,
    2. Alenazi AM,
    3. Hoover JC,
    4. Alshehri MM,
    5. Alghamdi MS,
    6. Osailan AM, et al.
    Incidence of stroke among Saudi population: a systematic review and meta-analysis. Neurological Sciences 2020; 41: 3099–3104.
    OpenUrl
  6. 6.↵
    1. Basri R,
    2. Issrani R,
    3. Hua Gan S,
    4. Prabhu N,
    5. Khursheed Alam M.
    Burden of stroke in the Kingdom of Saudi Arabia: A soaring epidemic. Saudi Pharm J 2021; 29: 264–268.
    OpenUrl
  7. 7.↵
    1. Feather A,
    2. Randell D,
    3. Waterhouse M. Kumar
    and Clark’s Clinical Medicine. 10th ed. Edinburgh: Elsevier; 2016.
  8. 8.↵
    1. Elkind M,
    2. Sacco R.
    Stroke Risk Factors and Stroke Prevention. Semin Neurol 1998; 18: 429–240.
    OpenUrlCrossRefPubMedWeb of Science
  9. 9.↵
    1. Shen Y,
    2. Shi L,
    3. Nauman E,
    4. Katzmarzyk P,
    5. Price-Haywood E,
    6. Bazzano A, et al.
    Association between Hemoglobin A1c and Stroke Risk in Patients with Type 2 Diabetes. J Stroke 2020; 22: 87–98.
    OpenUrl
  10. 10.↵
    Use of Glycated Haemoglobin (HbA1c) in the Diagnosis of Diabetes Mellitus Abbreviated Report of a WHO Consultation. Geneva (CH): World Health Organization; 2011. Available from: https://iris.who.int/bitstream/handle/10665/70523/WHO_NMH_CHP_CPM_11.1_eng.pdf?sequence=1
  11. 11.↵
    World Health Organization. Guideline for the pharmacological treatment of hypertension in adults. Geneva (CH): WHO; 2021. Available from: https://www.who.int/publications/i/item/9789240033986
  12. 12.↵
    1. Mitsios JP,
    2. Ekinci EI,
    3. Mitsios GP,
    4. Churilov L,
    5. Thijs V.
    Relationship Between Glycated Hemoglobin and Stroke Risk: A Systematic Review and Meta-Analysis. J Am Heart Assoc 2018; 7: e007858.
    OpenUrlAbstract/FREE Full Text
  13. 13.↵
    1. Kezerle L,
    2. Haim M,
    3. Akriv A,
    4. Senderey AB,
    5. Bachrach A,
    6. Leventer-Roberts M, et al.
    Relation of Hemoglobin A1C Levels to Risk of Ischemic Stroke and Mortality in Patients With Diabetes Mellitus and Atrial Fibrillation. Am J Cardiol 2022; 172: 48–53.
    OpenUrl
  14. 14.↵
    1. Lau L,
    2. Lew J,
    3. Borschmann K,
    4. Thijs V,
    5. Ekinci EI.
    Prevalence of diabetes and its effects on stroke outcomes: A meta-analysis and literature review. J Diabetes Investig 2019; 10: 780–792.
    OpenUrl
  15. 15.↵
    1. Homoud B,
    2. Alhakami A,
    3. Almalki M,
    4. Shaheen M,
    5. Althubaiti A,
    6. AlKhathaami A, et al.
    The association of diabetes with ischemic stroke and transient ischemic attacks in a tertiary center in Saudi Arabia. Ann Saudi Med 2020; 40: 449–455.
    OpenUrl
  16. 16.↵
    1. Al-Rubeaan K,
    2. Al-Hussain F,
    3. Youssef AM,
    4. Subhani SN,
    5. Al-Sharqawi AH,
    6. Ibrahim HM.
    Ischemic Stroke and Its Risk Factors in a Registry-Based Large Cross-Sectional Diabetic Cohort in a Country Facing a Diabetes Epidemic. J Diabetes Res 2016; 2016: 1–9.
    OpenUrlCrossRef
  17. 17.↵
    1. Al-Rajeh SM,
    2. Larbi EB
    , al-Freihi H, Ahmed K, Muhana F, Bademosi O. A clinical study of stroke. East Afr Med J 1989; 66: 183–191.
    OpenUrlPubMed
  18. 18.↵
    1. Madsen TE,
    2. Khoury JC,
    3. Leppert M,
    4. Alwell K,
    5. Moomaw CJ,
    6. Sucharew H, et al.
    Temporal Trends in Stroke Incidence Over Time by Sex and Age in the GCNKSS. Stroke 2020; 51: 1070–1076.
    OpenUrlCrossRef
  19. 19.↵
    1. Appelros P,
    2. Stegmayr B,
    3. Terént A.
    Sex Differences in Stroke Epidemiology. Stroke 2009; 40: 1082–1090.
    OpenUrlAbstract/FREE Full Text
  20. 20.↵
    1. Wang W,
    2. Jiang B,
    3. Sun H,
    4. Ru X,
    5. Sun D,
    6. Wang L, et al.
    Prevalence, Incidence, and Mortality of Stroke in China: Results from a Nationwide Population-Based Survey of 480 687 Adults. Circulation 2017; 135: 759–771.
    OpenUrlAbstract/FREE Full Text
  21. 21.↵
    1. Rexrode KM,
    2. Madsen TE,
    3. Yu AYX,
    4. Carcel C,
    5. Lichtman JH,
    6. Miller EC.
    The Impact of Sex and Gender on Stroke. Circ Res 2022; 130: 512–528.
    OpenUrlCrossRefPubMed
  22. 22.↵
    1. Vyas MV,
    2. Silver FL,
    3. Austin PC,
    4. Yu AYX,
    5. Pequeno P,
    6. Fang J, et al.
    Stroke Incidence by Sex Across the Lifespan. Stroke 2021; 52: 447–451.
    OpenUrlCrossRef
  23. 23.↵
    1. Petrea RE,
    2. Beiser AS,
    3. Seshadri S,
    4. Kelly-Hayes M,
    5. Kase CS,
    6. Wolf PA.
    Gender Differences in Stroke Incidence and Poststroke Disability in the Framingham Heart Study. Stroke 2009; 40: 1032–1037.
    OpenUrlAbstract/FREE Full Text
  24. 24.↵
    1. Wolf PA,
    2. Dawber TR,
    3. Thomas HE,
    4. Kannel WB.
    Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: The fiamingham Study. Neurology 1978; 28: 973–973.
    OpenUrlCrossRefPubMed
  25. 25.↵
    1. Wolf PA,
    2. Abbott RD,
    3. Kannel WB.
    Atrial fibrillation as an independent risk factor for stroke: the Framingham Study. Stroke 1991; 22: 983–988.
    OpenUrlAbstract/FREE Full Text
  26. 26.↵
    1. Chao TF,
    2. Liu CJ,
    3. Chen SJ,
    4. Wang KL,
    5. Lin YJ,
    6. Chang SL, et al.
    Atrial Fibrillation and the Risk of Ischemic Stroke. Stroke 2012; 43: 2551–2555.
    OpenUrlAbstract/FREE Full Text
  27. 27.↵
    1. Kannel WB.
    Manifestations of Coronary Disease Predisposing to Stroke. JAMA 1983; 250: 2942.
    OpenUrlCrossRefPubMedWeb of Science
  28. 28.↵
    1. Hata J,
    2. Kiyohara Y.
    Epidemiology of Stroke and Coronary Artery Disease in Asia. Circulation Journal 2013; 77: 1923–1932.
    OpenUrl
  29. 29.↵
    1. Kizer JR,
    2. Wiebers DO,
    3. Whisnant JP,
    4. Galloway JM,
    5. Welty TK,
    6. Lee ET, et al.
    Mitral Annular Calcification, Aortic Valve Sclerosis, and Incident Stroke in Adults Free of Clinical Cardiovascular Disease. Stroke 2005; 36: 2533–2537.
    OpenUrlAbstract/FREE Full Text
  30. 30.↵
    1. al Rajeh S,
    2. Awada A,
    3. Niazi G,
    4. Larbi E.
    Stroke in a Saudi Arabian National Guard community. Analysis of 500 consecutive cases from a population-based hospital. Stroke 1993; 24: 1635–1639.
    OpenUrlAbstract/FREE Full Text
  31. 31.↵
    1. El-Hajj M,
    2. Salameh P,
    3. Rachidi S,
    4. Hosseini H.
    The epidemiology of stroke in the Middle East. Eur Stroke J 2016; 1: 180–198.
    OpenUrl
  32. 32.↵
    1. Henriksson KM,
    2. Farahmand B,
    3. Åsberg S,
    4. Edvardsson N,
    5. Terént A.
    Comparison of Cardiovascular Risk Factors and Survival in Patients with Ischemic or Hemorrhagic Stroke. International Journal of Stroke 2012; 7: 276–281.
    OpenUrl
Back to top

In this issue

Print
Download PDF
Email Article
Citation Tools
Bookmark this article

Jump to section